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Abstract: HCl-demineralized murine lower incisors were implanted intramuscularly into 
syngeneic BALB/c mice to induce heterotopic osteogenesis. Implants were exposed at the 
early, preosteogenic stage (4), or at the later, osteogenic stage (12) to the Moloney sarcoma 
virus (MSV), which within 3–4 days results in a sarcoma. The yield of bone induction was 
determined by weight of dry bone mass following NaOH hydrolysis of soft tissues. To 
verify the effect of this sarcoma on orthotopic local femoral bone, the dry mass of the 
tumor-exposed femora was measured and compared with the weight of MSV-unexposed 
contralateral  controls.  MSV-sarcoma  or  cells  involved  with  their  spontaneous  rejection 
have a stimulatory effect on the periosteal membrane of the tumor-adjacent femoral bones, 
increasing their dry mass on average by 18%. No stimulatory effect on heterotopic bone 
induction was observed when the MSV sarcoma grew during the early, preosteogenic stage 
(4 onward), but when the tooth matrix had been exposed to such tumor at the already bone-
forming  stage,  (12  onward),  the  yield  of  bone  induction  was  enhanced.  Thus,  it  is 
postulated  that  lesions  induced  by  MSV  during  the  early,  preosteogenic  stage  inhibit 
recruitment  of  osteoprogenitor  cells  or  degrade  Bone  Morphogenetic  Proteins  (BMPs) 
released by matrix resorbing inflammatory cells, whereas when acting on already existing 
bone they have a stimulatory effect. 
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1. Introduction  
In rodents, the development of tumors by intramuscular injection of Moloney sarcoma virus (MSV) 
triggers a proliferative response of the periosteal membranes in tumor-adjacent bones. In such activated 
periosteum, proliferation and differentiation of chondro- and osteoprogenitor cells results in cartilage 
and  bone  matrix  deposition.  Thus,  the  process  of  periosteal  bone  formation  recapitulates  both 
endochondral and intramembranous osteogenesis, the last type dominating. The newly formed bone 
collar is firmly attached to maternal bone and is very slowly resorbed by osteoclasts, so in some cases 
an  increment  of  bone  mass,  sometimes  exceeding  100%  of  the  original  mass,  persists  for  several 
months post sarcoma development [1]. 
In  mice,  MSV-induced  tumors  appear  3–4  days  post  infection,  and  grow  progressively  for  
5–10 days, then gradually regress and disappear in most cases by day 16–20. The regression of these 
tumors are immunological events, mediated mainly by a cellular response [2–6], although a humoral 
response also contributes to some extent in tumor rejection [4,7]. 
Demineralized dentine is as efficient an inducer of cartilage and bone progenitor cell proliferation 
and  differentiation  as  is  demineralized  bone  [8–11].  On  implanting  into  a  muscular  pouch, 
demineralized dentine triggers differentiation of host mesenchymal cells to a chondro- and osteogenic 
lineage. In the model of heterotopic bone formation by tooth matrix, endochondral and mesenchymal-
type osteogenesis are present. 
Soluble  signals  released  from  demineralized  tooth  matrix  belong  to  the  family  of  Bone 
Morphogenetic Proteins (BMPs) that belong to the TGF-beta super family of proteins [12–14]. 
Mechanisms of regulation and maintenance of heterotopically formed bone are not fully understood 
[15], and there are a number of differences between ectopic and orthotopic bones. For example, ectopic 
bones  lack  true,  functioning  periosteal  and  endosteal  membranes  [16].  In  human  heterotopic 
ossification, the derived cells exhibited elevated levels of collagen synthesis and alkaline phosphatase 
activities ascribed to bone forming cells [17]. In general, heterotopic bone is metabolically more active 
than skeletal (orthotopic) bone. Toom et al. [18] found that the expression of BMP-2 and TGF are higher 
in ectopic bones and Chauvean et al. [19] reported strong over expression of osteocalcin mRNA, an 
event associated with upregulation of osteonectin and collagen type I synthesis. 
Demineralized bone matrix also contains proteins which inhibit the BMP activity both in vivo and  
in vitro [20]. Also, bone morphogenetic proteins BMP-3 and BMP-7 are regulators of bone inductive 
activity  of  demineralized  matrix  by  inhibition  of  osteoprogenitor  proliferation  and  stimulation  of 
differentiation and expression of bone markers [21,22]. 
The  immune  rejection  of  MSV-induced  tumors  releases  multiple  factors  influencing  bone 
homeostasis  [23].  Isolated  human  osteoblast  proliferation  may  be  either  activated  or  inhibited  by 
inflammatory  cytokines,  depending  on  their  concentration  and  duration  of  exposure  [24],  whereas Int. J. Mol. Sci. 2010, 11                       
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adjuvant-evoked  granuloma  cells  activate  endosteal  osteogenesis  [25].  Lesions  induced  by  T-cell 
mitogen Concanavalin A have increased the yield of demineralized tooth-induced bone [26]. 
The aim of this study is to examine the timing of MSV sarcoma induction on locally induced bone 
by demineralized murine lower incisors. In this study, MSV-sarcomas were induced during the early, 
preosteogenic stage of bone induction (virus injection 4 days post dentine implantation) or at a late 
stage, when chondro- and osteogenesis is advanced (virus injection 12 days post dentine implantation). 
The effect of MSV sarcoma on adjacent femoral bone was also monitored in order to compare the 
effectiveness of lesions on orthotopic and ectopic bones. 
2. Materials and Methods  
2.1. Demineralized Incisor Preparation and Characteristics 
Four to five-month-old BALB/c inbred female mice were used in our experiment in accordance with 
the Medical University of Warsaw’s guidelines for the care and use laboratory animals. The mandibles 
of the killed mice were removed and put into 0.6 N HCl, chilled on ice. After 60 min, the incisors were 
removed  from  the  alveolar  bone  and  transferred  to  a  fresh  HCl  solution  where  demineralization 
continued for another 3–4 hr, thus the duration of demineralization was 4–5 hr. The necrotic dental 
pulp in the crown and root of each incisor was removed by squeezing the demineralized tooth. Then 
incisors were vigorously washed in distilled water and lyophilized. 
Demineralization  of  adult  murine  incisors  for  4  hr  in  the  0.6  N HCl removes completely their 
mineral phase. The mean wet weight of isolated incisors demineralized for 4 hr was 4.86 ± 1.0 mg  
(n = 13) and was equal to the specimens demineralized for 22 hr (mean weight 4.81 ± 0.7 mg, n = 9). 
Perhaps some traces of mineral remained following the procedure, but did not affect bone induction. 
The  prolonged  hydrolysis  of  murine  incisors  for  22  hr  slightly  reduces  the  yield  of  bone  
induction [26]. 
The 4 hr lyophilized demineralized female mature BALB/c lower incisors are very homogenous. 
Their average weight was 0.95 ± 0.05 mg (n = 17), thus we considered them as a standard dose of Bone  
Inducing Principle. 
2.2. Implantation of Demineralized Incisors 
The animals were anesthetized with an intraperitoneal injection containing Rompun (Bayer AG, 
Leverkusen, Holland) and Calypsol (G. Richter, Budapest, Hungary). After shaving, short (4–5 mm) 
longitudinal  skin  and  muscle  incisions  were  made  on  the  inner  side  of  the  left  and  right  thighs. 
Lyophilized incisors were inserted into the muscle pockets, the skin was sutured with a 3-0 Dexon “S” 
polyglycolic acid suture, and the wounds were disinfected with 70% alcohol. 
Individual recipient mice received bilateral implants from one set of prepared incisors. Four or 
twelve  days  after  implantation,  the  left  or  right  limb  was  injected  with  0.2  mL of standard MSV 
suspension, the contralateral right or left limb was injected with saline only. On average, half of the 
animals  were  injected  in  left  limb,  and  half  were  injected  in  right  limb,  in  order  to  exclude  the 
influence of manual inconsistencies in the surgical procedure. Int. J. Mol. Sci. 2010, 11                       
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The MSV preparation was a saline homogenate of the tumor, grown in a newborn BALB/c mouse 
following  inoculation  of  MSV.  The  tumor  was  harvested  two  weeks  post  inoculation.  The  virus 
suspension used in these experiments was prepared according to Chanaille et al. [27]. 
Animals were observed daily, and the time of tumor appearance, growth and disappearance was 
recorded. Animals which did not develop a tumor (5% of cases) were excluded. 
Animals were killed by cervical dislocation following CO2 inhalation, four weeks following incisor 
implantation, to assess bone induction yield. 
2.3. Assessment of Excised Implants and of Femoral Bone 
The implants, together with the surrounding thigh muscles, were excised and hydrolyzed overnight 
in 0.1 N NaOH at 64 °C. 
The demineralized incisors and soft tissues were completely dissolved during hydrolysis, without 
affecting  mineralized  tissue  mass.  Thus,  the  undigested  material  recovered  was  solely  mineralized 
component  of  bone  tissue.  These  undigested  deposits  were  washed  in  distilled  water  and  dried 
overnight at 64
 °C. The dried mineral was weighed to an accuracy of ±0.1 mg. 
The femoral bones from both limbs were excised and hydrolyzed as above. The femoral bone dry 
mass was measured to the same accuracy, providing information on the effect of MSV sarcoma on 
adjacent femoral bone. The femoral dry bone mass gain following MSV sarcoma development was 
expressed as a percentage of dry mass of the contralateral bone not exposed to the tumor. 
2.4. Histology 
The implant and surrounding tissues were fixed in Bouin fixative, decalcified in a saturated solution 
of EDTA, embedded in paraffin and sectioned at 8 µm. Sections were stained with PAS-hematoxylin 
and examined with the light microscope. 
The number of animals, their division into groups according to the MSV-injection schedule, and the 
bone induction yields are shown in Table 1. 
2.5. Statistical Analysis  
Student’s  t-test  was  used  to  test  for  significant  differences  between  the  induced  bone  yields. 
Differences were considered significant when the p value was less than 0.05. Statistical analysis was 
performed using SAS V.6.12 for Windows software, (SAS Institute, USA). 
3. Results 
Demineralized murine incisor matrix, implanted intramuscularly into syngeneic mice, induces bone 
formation to varying degrees (Figure 1). The swellings at the sites of MSV inoculation were observed 
as  early  as  day  3  post  inoculation.  Tumors  grew  progressively  up  to  10  days  and  then  gradually 
regressed, in most cases until day 16, in a few cases until day 22. Int. J. Mol. Sci. 2010, 11                       
 
 
3281
Figure 1. Enlarged macroscopic view of spicules of mineralized tissue recovered by the 
NaOH  hydrolysis  of  the  ectopic  bone  induction  by  demineralized  incisor  implants.  
Bar represents 500 µm. 
  
The MSV-induced tumors are pleomorphic and have a high mitotic rate. During the progressive 
stage  of  tumor  growth,  massive  destruction  of  muscle  was  always  observed  at  the  site  of  virus 
inoculation,  and  tumor  regression  was  associated  with  the  regeneration  of  skeletal  muscles, 
disappearance of neoplastic cells, and the accumulation in the lesion of macrophages, lymphocytes and 
fibroblasts. Between days 22–28, there was no macroscopic evidence of tumor, and both hind limbs 
appeared identical. 
The yield of mineralized bone induced by implanted demineralized incisors in the sites exposed to 
MSV tumor during the early phase of induction (virus injection on day 4), was of the same magnitude, 
as in the non-exposed contralateral site, (0.37 ± 0.34 mg vs. 0.46 ± 0.38 mg; difference not significant, 
t = 1.113).  
In contrast, a stimulatory effect was observed when MSV tumor grew during the osteogenic stage of 
induction,  i.e.,  when  MSV  was  administered  on  day  12  post  incisor  grafting,  (0.72  mg  ±  0.39  
vs. 0.45 ± 0.34, difference significant at 0.02 < p < 0.05, t = 2.254). 
The yield of bone induction at the contralateral, non-MSV-exposed sites was similar in the 4- and 
12-day groups, indicating a lack of systemic effect of MSV-induced tumor (Figures 2 and 3). 
In  all  instances,  the  exposure  of  orthotopic  femoral  bone  to  MSV  sarcoma  always  activated 
periosteal osteogenesis (Table 1, Figure 4). The mean increment of dry mass of femoral bones exposed 
to the MSV-induced sarcoma varied from 3 to 73%, and on average was 17.6% ± 16.7%. Int. J. Mol. Sci. 2010, 11                       
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Figure 2. Cartilage (C) formation by demineralized incisor (DI) 10 days post implantation. 
Hematoxylin-eosin staining. Bar represents 100 µm. 
 
Figure 3. Bone (B) and bone marrow (BM) formed 28 days post demineralized incisor (DI) 
implantation, not exposed to MSV. Hematoxylin-eosin staining. Bar represents 100 µm. 
 Int. J. Mol. Sci. 2010, 11                       
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Table  1. The timing effect of MSV-sarcoma development on bone induction following 
intramuscular implantation of demineralized lower incisor matrix in BALB/c mice, 28 days 
post implantation. 
Time of MSV-
inoculation post 
incisor 
implantation (day) 
Yield of bone 
induction (mg) at 
MSV-sarcoma 
lesions* 
Yield of bone 
induction (mg) at 
contralateral site, not 
exposed to MSV* 
Yield of femoral bone 
increment following 
MSV sarcoma exposure 
(% of original weight)** 
4  (53)   0.37 ± 0.34  (55)   0.46 ± 0.38  (90)   17.6 ± 16.7 
12  (32)   0.73 ± 0.39  (32)   0.48 ± 0.34   
*  Yield is represented as the mean weight ±S.D. 0.02 < p < 0.05 by Student t-test. In parenthesis 
is number of implants or paired femoral bones examined. 
**  % of dry mass gain of the MSV-exposed femora against MSV-unexposed contralateral control. 
The figures in parenthesis are numbers of mice. 
Figure 4. Activation of periosteal membrane of femoral bone at the site of MSV-sarcoma 
development,  9  days  post  MSV  infection;  PAS  reaction.  Arrows  point  to  the  edge  of 
femoral  shaft.  NB—newly  formed  bone  trabeculae  within  activated  periosteum.  
Bar represents 50 µm. 
 
4. Discussion  
Ectopic  cartilage/bone  formation  by  demineralized  tooth  matrix  is  a  well-known  phenomenon 
[10,11,14], triggered by the release of bone morphogenetic proteins (BMPs) from the implant.  Int. J. Mol. Sci. 2010, 11                       
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Periosteal  bone  induction  is  initiated  by  cells  residing  in  the  periosteal  membrane,  which  are 
activated by growth factors that are released during immune-mediated spontaneous regression of the 
tumor MSV-induced [1,28], or by lesions elicited by the T cell mitogen Concanavalin A [29]. 
The present studies were designed to determine the effect of the development of Moloney sarcoma 
on bone induction following intramuscular implantation of syngeneic demineralized lower incisors in 
mice.  Murine  incisors  hydrolyzed  for  4–5  hr  in  chilled  0.6  N  HCl  were  fully  demineralized  and 
exhibited good osteoinductive potency. We previously showed that 22 hr demineralization slightly 
diminishes their osteoinductive power, most likely by affecting their organic phase [26]. 
We  previously  histologically  examined  the  early  stages  of  murine  demineralized  incisor 
implantation into the thigh muscles, and the earliest cartilage and bone formation was recorded on Day 
8. On Day 12, bone trabeculae formed by endochondral or mesenchymal-type osteogenesis were well 
developed. 
Lesions induced by MSV injection during the preosteogenic stage of bone induction (day 4) had no 
significant effect on ectopic bone yield, although the mean values of bone induction were lower than 
those for the contralateral, MSV-unexposed implants. In contrast, the exposure of already existing 
induced bone (12 days) to MSV significantly enhanced the yield of induced bone at those sites. 
MSV sarcoma always activated the periosteal membrane of the tumor-adjacent femoral bones to 
deposit new bone, and the dry mass femoral bone increment varied between 3–78% over the control, 
and was on average about 18%.  
Ectopic bones lack a true periosteum, thus the mechanism of incremental growth of heterotopic 
bone following MSV-sarcoma exposure must differ from that activating orthotopic bones. 
According to Friedenstein [30], osteogenesis in ectopic bones is provided by two different kinds of 
precursor  cell:  (1)  inductor-dependent  clonogeneic  cells  responsible  for  maintenance  of  the 
mechanocyte  cell  population—Inducible  Osteogenic  Precursor  Cells,  IOPC,  and  (2)  inducer-
independent descendants of clonogenic cells—Determined Osteogenic Precursor Cells, DOPC. 
We speculate that cytokines or cells generated by the immune reaction which leads to sarcoma 
rejection are unable to activate recruitment and proliferation of Inducible Osteoprogenitor Cells, the 
early stage of induction event, but are able to activate Determined Osteoprogenitor Cells descendents 
of IOPC. Osteoblasts residing in the periosteal membrane of orthotopic bone belong to the DOPC 
category, thus are susceptible to osteogenic activators. 
Another possible explanation for the lack of stimulatory effect on ectopic osteogenesis when MSV 
sarcoma has developed during an early, preosteogenic stage, is degradation by the tumor or by cells 
involved in its rejection of BMP released from implanted matrix. Spontaneous regression of MSV 
sarcoma  is  a  manifestation  of  a  strong  cellular  response,  mainly  executed  by  macrophages,  thus  
the presence of proteolytic enzymes in such lesions is possible. Tumor-associated macrophages release 
cathepsin,  whereas  LPS  activated  peritoneal  macrophages  release  caspases,  both  are  proteolytic  
enzymes [31,32]. Molecules involved in ectopic bone homeostasis seem to differ in the Con A and in 
the  MSV-evoked  inflammatory  reactions,  as  is  in  the  case  in  chronic  inflammatory  
diseases—rheumatoid-artritis and ankylosing spondylitis [33]. 
There is a difference in the effect of mediators released by lesions following the T cell mitogen 
Concanavalin A on ectopic bone by demineralized incisors and by the Moloney sarcoma. The first Int. J. Mol. Sci. 2010, 11                       
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increases yield of demineralized incisor-induced bone when injected during the preosteogenic stage of 
induction, an effect not observed when Con A was injected after heterotopic osteogenesis had been 
established.  This  might  suggests  that  Con  A,  in  contrast  to  the  Moloney  sarcoma,  recruits  early 
osteoprogenitor cells, but does not differentiate chondroblasts and osteoblasts. Thus, we postulate that 
MSV  sarcoma  does  not  recruit  such  cells,  but  does  activate  determined  cells,  as  in  the  case  of 
periosteum activation [1]. 
5. Conclusion 
In the model of heterotopic osteogenesis by syngeneic demineralized lower incisors implanted into 
thigh muscles in mice, the Moloney sarcoma development during the osteogenic stage (day 12 of bone 
induction), but not during the preosteogenic stage (day 4 of induction) increased the yield of bone 
induction.  This  suggests  that  MSV  sarcoma  activates  determined  osteoprogenitor  cells,  but  has 
minimal, if any, effect on their recruitment. 
References 
1.  Włodarski, K.; Kobus, M.; Łuczak, M. Orthotopic bone induction at sites of Moloney murine 
sarcoma virus inoculation in mice. Nature 1979, 281, 386–387. 
2.  Fefer, A.; McCoy, J.L.; Glynn, J.P. Induction and regression of primary Moloney sarcoma virus-
induced tumors in mice. Cancer Res. 1967, 27, 1626–1631. 
3.  Fefer, A.; McCoy, J.L.; Glynn, J.P. Immunologic, virologic and pathological studies of regression 
of  autochtonous  Moloney  sarcoma  virus-induced  tumors  in  mice.  Cancer  Res.  1968,  28,  
1577–1585. 
4.  Fefer, A. Immunotherapy and chemotherapy of Moloney sarcoma virus-induced tumors in mice.  
Cancer Res. 1969, 29, 2177–2183. 
5.  Stutman, O. Delayed tumor appearance and absence of regression in nude mice infected with 
murine sarcoma virus. Nature 1975, 253, 142–144. 
6.  Russel, S.W.; McIntosh, A.T. Macrophages isolated from regressing Moloney sarcoma are more 
cytotoxic than those recovered from progressing sarcomas. Nature 1977, 268, 68–71. 
7.  Friedlander,  G.E.;  Mitchell,  M.S.  A  virally  induced  osteosarcoma  in  rats.  A  model  for 
immunological studies of human osteosarcoma. J. Bone Joint Surg. 1976, 58, 295–302. 
8.  Huggins,  C.B.;  Urist,  M.R.  Dentine  matrix  transplantation.  Rapid  induction  of  alkaline 
phosphatase and cartilage. Science 1970, 167, 896–898. 
9.  Urist,  M.R.  Bone  histogenesis  and  morphogenesis  in  implants  of  demineralized  enamel  and 
dentine. J. Oral Surg. 1971, 29, 88–102. 
10.  Amar, S.; Sires, B.; Clohisy, J.; Veis, A. The isolation and partial characterization of a root incisor 
dentin  matrix  polypeptide  with  in  vitro  chondrogenic  activity.  J.  Biol.  Chem.  1991,  266,  
8609–8618. 
11.  Ike,  M.;  Urist,  M.R.  Recycled  dentine  root  matrix  for  a  carrier  of  recombinant  human  bone 
morphogenetic protein. J. Oral Implantol. 1998, 24, 124–132. Int. J. Mol. Sci. 2010, 11                       
 
 
3286
12.  Wang, E.A.; Rosen, V.; Cordes, P.; Hewick， R.M.; Kriz, M.J.; Luxenberg, D.P.; Sibley, B.S.; 
Wozney, J.M. Purification and characterization of other distinct bone-inducing factors. Proc. Natl. 
Acad. Sci. USA 1988, 85, 9484–9488. 
13.  Wozney,  J.M.;  Rosen,  V.;  Celeste,  A.J.;  Mitsock,  L.M.;  Whitters,  M.J.;  Kriz,  R.W.;  
Hewick, R.M.; Wang, E.A. Novel regulators of bone formation: molecular clones and activities.  
Science 1988, 242, 1528–1534. 
14.  Sampath, T.K.; Maliakal, J.C.; Hauschka, P.V.; Jones, W.K.; Sasak, H.; Tucker, R.F.; White, 
K.H.; Coughlin, J.E.; Tucker, M.M.; Pang, R.H. et al. Recombinant human osteogenic protein-1 
(hOP-1) induces new bone formation in vivo with a specific activity comparable with natural 
bovine osteogenic protein and stimulates osteoblast proliferation and differentiation in vitro. J. 
Biol. Chem. 1992, 267, 20352–20362. 
15.  De Vlam, K.; Lories, R.J.; Luyten, F.P. Mechanisms of pathological new bone formation. Curr. 
Rheumatol. Rev. 2006, 8, 332–337. 
16.  Włodarski, K.; Reddi, A.H. Heterotopically induced bone does not develop functional periosteal 
membrane. Arch. Immunol. Therap. Exp. 1986, 34, 385–395. 
17.  Kaysinger, K.K.; Ramp, W.K.; Lang, G.J.; Gruber, H.E. Comparison of human osteoblasts and 
osteogenic cells from heterotopic bone. Clin. Orthop. Rel. Res. 1997, 342, 181–191. 
18.  Tom, A.; Arend, A.; Gunnarsson, D.; Ulfsparre, R.; Suutre, S.; Haviko, T.; Selstam, G. Bone 
formation zones in heterotopic ossifications: histology findings and increase expression of bone 
morphogenetic protein 2 and transforming growth factors beta2 and beta3. Calcif. Tissue. Int. 
2007, 80, 259–267. 
19.  Chauvean, D.; Devedjian, J.C.; Blary, M.C.; Delecourt, C.; Hardouin, P.; Jeanfils, J.; Broux, O. 
Gene expression in human osteoblastic cells from normal and heterotopic ossification. Exp. Mol. 
Pathol. 2004, 76, 37–43. 
20.  Brownell,  A.G.  Osteogenesis  inhibitory  protein:  a  (p)review.  Connect.  Tissue  Res.  1990,  24,  
13–16. 
21.  Amedee, J.; Bareille, R.; Rouais, F.; Cunningham, N.; Reddi, A.H.; Harmand, M.F. Osteogenin 
(bone  morphogenetic  protein  3)  inhibits  proliferation  and  stimulates  differentiation  of 
osteoprogenitors in human bone marrow. Differentiation 1994, 58, 157–164. 
22.  Maliakal,  J.C.;  Asahima,  I.;  Hauschka,  P.V.;  Sampath,  T.K.  Osteogenic  protein-1  (BMP-7) 
inhibits cell proliferation and stimulates the expression of markers characteristicc of osteoblast 
phenotype in rat osteosarcoma (17/2.8) cells. Growth Factors 1994, 11, 227–234. 
23.  Goldring, S.R. Inflammatory mediators as essential elements in bone remodeling. Calcif. Tissue 
Int. 2003, 73, 97–100. 
24.  Frost, A.; Jonsson, K.B.; Nilsson, O.; Ljunggern, O. Inflammatory cytokines regulate proliferation 
of cultured human osteoblasts. Acta. Orthop. Scand. 1997, 68, 91–96. 
25.  Tomoda, K.; Kitaoka, M.; Iyama, K.; Usuku, G. Endosteal new bone formation in the long bones 
of adjuvant treated rats. Pathol. Res. Pract. 1986, 181, 331–338. 
26.  Włodarski, P.; Galus, R.; Włodarski, K.H.; Brodzikowska, A. Heterotopic osteogenesis by murine 
demineralized incisors at lesions sites induced by Concanavalin A in mice. Connect. Tissue. Res.  
2009, 50, 1–6. Int. J. Mol. Sci. 2010, 11                       
 
 
3287
27.  Chanaille, P.; Levy, J.P.; Tacitan, G.J. Routine method for concentration and partial purification 
of a murine leukemia virus (Rausher). Nature 1967, 213, 107–109. 
28.  Włodarski, P.; Sevignani, C.; Fernandez, M.J.; Calabretta, B.; Włodarski, K.H. Tumor induced by 
Moloney sarcoma virus causes periosteal osteogenesis engaging osteopontin, stromelysin-1 and 
tenascin. Neoplasma 2007, 54, 173–179. 
29.  Włodarski,  K.;  Galus,  K.  Osteoblastic  and  chondroblastic  response  to  variety  of  locally 
administered immunomodulators in mice. Folia Biol. (Praha) 1992, 38, 284–292. 
30.  Friedenstein, A.J. Precursor cells of mechanocytes. Int. Rev. Cytol. 1976, 47, 327–359. 
31.  Ohno, T.; Oboki, K.; Kajiwara, N.; Morii, E.; Aozasa, K.; Flawell, R.A.; Okumura, K.; Saito, H.; 
Nakae, S. Caspase-1, caspase-8, and calpain are dispensable for IL-33 release by macrophage. J. 
Immunol. 2009, 183, 7890–7897. 
32.  Gocheva,  V.;  Wang,  H.W.;  Gadea,  B.B.;  Shree,  T.;  Hunter,  K.E.;  Garfall,  A.L.;  Berman,  T.;  
Joyce, J.A. IL-4 induces cathepsin protease activity in tumor-associated macrophages to promote 
cancer growth and invasion. Genes Dev. 2010, 24, 241–255. 
33.  Schett G.; Sieper J. Inflammation and repair mechanisms. Clin. Rheumatol. 2009, 27, 33–35. 
©  2010  by  the  authors;  licensee  MDPI,  Basel,  Switzerland.  This  article  is  an  open  access  article 
distributed  under  the  terms  and  conditions  of  the  Creative  Commons  Attribution  license 
(http://creativecommons.org/licenses/by/3.0/). 